No Data
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Yunkang Group Plans Key Procurement Agreement With Daan Gene
Yunkang Group Delays Dispatch of Key Procurement Circular
Is Yunkang Group (HKG:2325) Using Debt Sensibly?
YUNKANG GROUP: 2024 INTERIM REPORT
No Data